Steminent Biotherapeutics, Inc (TPEX:7729)
Taiwan
· Delayed Price · Currency is TWD 20.50
-0.30 (-1.44%)
Jun 25, 2025, 12:46 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 1.17 billion as of June 25, 2025. Its market cap has decreased by -29.92% in one year.
Market Cap
1.17B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.50
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has decreased from 2.24B to 1.17B, a decrease of -47.90%. That is a compound annual growth rate of -39.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 1.17B | -9.12% |
| Dec 31, 2024 | 1.28B | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 191.55B |
| PharmaEssentia | 175.96B |
| Bora Pharmaceuticals Co., LTD. | 82.45B |
| Lotus Pharmaceutical | 55.88B |
| Oneness Biotech | 31.04B |
| Polaris Group | 28.85B |
| Center Laboratories | 26.85B |
| TaiMed Biologics | 26.11B |